Literature DB >> 7030293

Glyoxalase phenotypes in patients with diabetes mellitus.

V J McCann, R E Davis, T A Welborn, I J Constable, D G Beale.   

Abstract

Caucasian diabetic patients in Australian surveys showed a significant difference in the distribution of glyoxalase phenotypes. Insulin dependent diabetic patients with age of onset less than 40 years had a relative excess of glyoxalase homozygote 1-1 and a deficiency of types 2-1 and 2-2. Non-insulin dependent diabetic patients were not significantly different from non-diabetic subjects in the distribution of glyoxalase phenotypes. Insulin dependent diabetic patients without the complications of retinopathy or neuropathy also showed a significant excess of glyoxalase type 1-1 in relation to the control group. Genes controlling glyoxalase polymorphism appear to be associated with the variations of diabetes and its complications.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7030293     DOI: 10.1111/j.1445-5994.1981.tb03516.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  6 in total

Review 1.  The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

2.  HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.

Authors:  J McCluskey; V J McCann; P H Kay; P J Zilko; F T Christiansen; G J O'Neill; R L Dawkins
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

3.  Methylglyoxal, glyoxalases and the development of diabetic complications.

Authors:  P J Thornalley
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

4.  Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project.

Authors:  Guenet H Degaffe; David L Vander Jagt; Arlene Bobelu; Jeanette Bobelu; Donica Neha; Mildred Waikaniwa; Philip Zager; Vallabh O Shah
Journal:  J Diabetes Complications       Date:  2008-04-16       Impact factor: 2.852

5.  Extended major histocompatibility complex haplotypes in type I diabetes mellitus.

Authors:  D Raum; Z Awdeh; E J Yunis; C A Alper; K H Gabbay
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

Review 6.  The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).

Authors:  Marcus Hollenbach
Journal:  Int J Mol Sci       Date:  2017-11-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.